URB-597

• Background:

  Potent and selective fatty acid amide hydrolase (FAAH) inhibitor, IC50 = 3-5 nM1. Produces cannabinoid CB1 and CB2 receptor-mediated analgesia in inflammatory pain states without causing side effects associated with cannabinoid receptor activation2. Attenuates the anxiolytic-like effect of acetaminophen in a mouse model3. Exerts anti-inflammatory effects in rat hippocampus and ameliorates age-related deficits4. Off target effects: Reduces tyrosine hydroxylase expression5.

• Conjugation:

  Unconjugated

• Buffer:

  Off-white solid

• Storage Conditions:

  RT